[HTML][HTML] Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification

JC Kasius, JMA Pijnenborg, K Lindemann, D Forsse… - Cancers, 2021 - mdpi.com
Simple Summary Endometrial cancer (EC) is the most common gynaecologic malignancy in
developed countries. Most patients are sufficiently treated with removal of uterus, tubes and …

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

JC Kasius, JMA Pijnenborg, K Lindemann… - …, 2021 - cris.maastrichtuniversity.nl
Abstract Simple Summary: Endometrial cancer (EC) is the most common gynaecologic
malignancy in developed countries. Most patients are sufficiently treated with removal of …

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

JC Kasius, JMA Pijnenborg… - …, 2021 - researchinformation.amsterdamumc …
Endometrial cancer (EC) is the most common gynaecologic malignancy in developed
countries. The main challenge in EC management is to correctly estimate the risk of …

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification.

JC Kasius, JMA Pijnenborg, K Lindemann, D Forsse… - Cancers, 2021 - europepmc.org
Endometrial cancer (EC) is the most common gynaecologic malignancy in developed
countries. The main challenge in EC management is to correctly estimate the risk of …

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

JC Kasius, JMA Pijnenborg, K Lindemann… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Endometrial cancer (EC) is the most common gynaecologic malignancy in developed
countries. The main challenge in EC management is to correctly estimate the risk of …

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

JC Kasius, J Pijnenborg, K Lindemann, D Forsse… - Cancers, 2021 - lirias.kuleuven.be
Endometrial cancer (EC) is the most common gynaecologic malignancy in developed
countries. The main challenge in EC management is to correctly estimate the risk of …

[HTML][HTML] Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

JC Kasius, JMA Pijnenborg, K Lindemann, D Forsse… - Cancers, 2021 - ncbi.nlm.nih.gov
Endometrial cancer (EC) is the most common gynaecologic malignancy in developed
countries. The main challenge in EC management is to correctly estimate the risk of …

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

JC Kasius, JMA Pijnenborg, K Lindemann, D Forsse… - …, 2021 - search.proquest.com
Endometrial cancer (EC) is the most common gynaecologic malignancy in developed
countries. The main challenge in EC management is to correctly estimate the risk of …

Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification

JC Kasius, J Pijnenborg, K Lindemann, DE Forsse… - Cancers, 2021 - duo.uio.no
Endometrial cancer (EC) is the most common gynaecologic malignancy in developed
countries. The main challenge in EC management is to correctly estimate the risk of …

[PDF][PDF] Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification. Cancers 2021, 13, 5848

JC Kasius, JMA Pijnenborg, K Lindemann, D Forsse… - 2021 - pdfs.semanticscholar.org
Endometrial cancer (EC) is the most common gynaecologic malignancy in developed
countries. The main challenge in EC management is to correctly estimate the risk of …